Kathryn Romano sells 12,500 KRYS shares

Kathryn Romano reported sales and an intended sale of KRYS common stock.

Accepted by SEC EDGAR 03/02/2026 - 12:56 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Kathryn Romano reported sales and an intended sale of KRYS common stock. The filing shows 12,500 common shares were sold on 02/09/2026 for $3,401,705.00. It also lists 750 restricted shares tied to vesting as compensation on 02/27/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kathryn Romano report in the KRYS Form 144?

Kathryn Romano reported a disposition of 12,500 common shares on 02/09/2026 for $3,401,705.00. The filing also lists 750 restricted shares associated with vesting on 02/27/2026 as compensation.

How many KRYS shares were sold in the past three months?

The filing shows a sale of 12,500 common shares on 02/09/2026 with an aggregate amount of $3,401,705.00. This figure is reported under "Securities Sold During The Past 3 Months."

What securities are listed as to be sold for KRYS?

The filing lists 750 common shares described as "Restricted Stock Vesting" tied to compensation with an effective date of 02/27/2026. The entry is shown under "Securities To Be Sold."

Through which broker or account is the KRYS sale noted?

The entry references Fidelity Brokerage Services LLC at the address shown and lists 750 in connection with that broker. The filing pairs the broker line with the restricted-share entry dated 02/27/2026.

Does the KRYS Form 144 show additional cash or pricing details?

Yes; the sale of 12,500 shares on 02/09/2026 is shown with an aggregate amount of $3,401,705.00. No per-share price or further proceeds allocation is provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001801385
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Krystal Biotech, Inc.
SEC File Number	001-38210
Address of Issuer	2100 WHARTON STREET SUITE 701 PITTSBURGH PENNSYLVANIA 15203
Phone	(412) 586-5830
Name of Person for Whose Account the Securities are To Be Sold	ROMANO KATHRYN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	750	200700.00	29232189	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2026	Restricted Stock Vesting	Issuer			750	02/27/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kathryn Romano 2100 Wharton Street Suite 701 Pittsburgh PA 15203	Common	02/09/2026	12500	3401705.00

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kathryn Romano.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)